You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Eurofins to acquire Villapharma in Spain
State Of Singapore Online Video Subscription
Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition
Episode 43 - More Change, M&A On Horizon For Equity Research Industry
Cable Nets Struggle With Little Revenue Growth Expanding Programming Budgets
Eurofins Scientific SE is acquiring Villapharma Research SL in Spain for undisclosed terms.
The transaction is expected to close in February 2017 and will help Eurofins reinforce its footprint in discovery pharmacology.
Villapharma is a provider of organic synthesis and medical chemistry services to pharmaceutical and biotech companies. The company is expected to generate more than €6 million in revenues this year.